From: Choice of Moisturiser for Eczema Treatment (COMET): study protocol for a randomized controlled trial
Data collected | Frequency and timing of data collection | ||||
---|---|---|---|---|---|
Baseline | Months 1–3 | End of study | |||
Daily | Weekly | Monthly | |||
Medical history | R | ||||
Eczema Area and Severity Index | R | ||||
Six Area, Six Sign Atopic Dermatitis severity score | R | ||||
Three Item Severity score | R | ||||
Skin corneometry | R | ||||
Study emollient use | P | ||||
Other emollient or bath additive use | P | ||||
Topical corticosteroid or calcineurin inhibitor use | P | ||||
Patient-Orientated Eczema Measure | GP, PN or R | P | |||
Health care consultation attendance | P | ||||
Eczema-related costs (out-of-pocket expenditure by parent) | P | ||||
Time off work and nursery or day care due to eczema | P | ||||
Dermatitis Family Impact | R | P | |||
Patient Global Assessment | R | P | |||
Quality of life | R | P | |||
Review of electronic medical record | GP or PN |